Latest News for NetEase Stock (OTC:NETTF)

NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).

NetEase Inc

BMO Capital analyst Keith Bachman maintains IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) with a Market Perform and lowers the price target from $210 to $190.

News

Price Target

Analyst Ratings

BMO Capital Maintains Market Perform on IBM, Lowers Price Target to $190

Asset Sales

Legal

AMZN

GOOG

GOOGL

SNAP

TikTok Owner ByteDance To Prefer Shutting Down Of Loss-making App Rather Than A Sale If Exhausts All Legal Options; Algorithms TikTok Relies On Deemed Core To ByteDance Overall Operations, Making Sale Of App Unlikely, Sources Say

WIIM

SPCB

SuperCom shares are trading higher after the company announced it received over $5 million in New Orders from European governments.

BMO Capital analyst Keith Bachman maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Outperform and lowers the price target from $850 to $830.

BMO Capital Maintains Outperform on ServiceNow, Lowers Price Target to $830

RBC Capital analyst Brad Erickson maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Outperform and lowers the price target from $600 to $570.

RBC Capital Maintains Outperform on Meta Platforms, Lowers Price Target to $570

JP Morgan analyst Stephen Tusa maintains Otis Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>) with a Neutral and raises the price target from $104 to $105.

OTIS

JP Morgan Maintains Neutral on Otis Worldwide, Raises Price Target to $105

POAI

Predictive Oncology shares are trading higher after the company announced that it entered into a collaboration and co-marketing agreement with FUJIFILM Wako Chemicals U.S.A. to reduce protein interference in bacterial endotoxin testing of biopharmaceutical products.

JP Morgan analyst Stephen Tusa maintains Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) with a Underweight and raises the price target from $350 to $360.

JP Morgan Maintains Underweight on Lennox Intl, Raises Price Target to $360

<a href="https://www.reuters.com/markets/deals/anglo-american-does-not-find-bhp-39-bln-offer-attractive-sources-say-2024-04-25/#:~:text=LONDON%2C%20April%2025%20(Reuters),investors%20dismissed%20it%20as%20opportunistic.">https://www.reuters.com/markets/deals/anglo-american-does-not-find-bhp-39-bln-offer-attractive-sources-say-2024-04-25/#:~:text=LONDON%2C%20April%2025%20(Reuters),investors%20dismissed%20it%20as%20opportunistic.</a>
&nbsp;
Anglo American does not consider a proposed $39 billion takeover offer from BHP Group as attractive, two sources told Reuters, as some large investors dismissed it as opportunistic.
BHP on Thursday offered <a href="https://www.reuters.com/markets/deals/bhp-considering-potential-buyout-offer-anglo-american-bloomberg-reports-2024-04-24/">Anglo's shareholders</a> 25.08 pounds ($31.39) per share, or $38.8 billion, a premium of 31% to the market close on Wednesday. It would take over Anglo after a spin-off of two assets.
Speaking on condition of anonymity because the matter is private, one of the sources said the offer did not address the complexities of demerging the Anglo American Platinum and Kumba Iron Ore businesses in South Africa.
BHP has until May 22 to come back with a binding bid, but Anglo's board will give a formal response in the coming days.
For now, Anglo, which has a market value of $36.7 billion, said it would be reviewing the offer, without elaborating.
The proposed tie-up would create a group with around one tenth of the global output of copper, which is in demand for its use in electric vehicles and new technologies, such as automation and artificial intelligence.
BHP has made the offer as the company continues a strategic <a href="https://www.reuters.com/markets/commodities/anglo-american-full-year-profit-plunges-by-94-2024-02-22/">review</a> of its assets started in February in response to a 94% fall in annual profit and a series of writedowns caused by to lower commodity demand.
One of the source said Anglo American's management was continuing "full steam ahead" with the review.

"Anglo American Does Not Find BHP $39B Offer Attractive, Sources Say" - Reuters News

RBC Capital analyst Arun Viswanathan maintains Sherwin-Williams (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) with a Outperform and lowers the price target from $380 to $370.

RBC Capital Maintains Outperform on Sherwin-Williams, Lowers Price Target to $370

Thursday,&nbsp;Bristol Myers Squibb &amp; Co&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) posted first-quarter revenues of $11.9 billion, beating the consensus of $11.5 billion, an increase of 5% year-over-year, or 6% when adjusted for foreign exchange impacts, primarily driven by Eliquis,&nbsp;Reblozyl, and Opdualag,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/b38426021/bristol-myers-squibb-reports-first-quarter-financial-results-for-2024" rel="noreferrer noopener">partially offset by Opdivo and Revlimid</a>.
Growth Portfolio worldwide revenues increased to&nbsp;$4.8 billion, up 8% or 11% when adjusted for foreign exchange impacts.&nbsp;
This increase was primarily driven by higher demand for&nbsp;Reblozyl, Opdualag, Yervoy, Camzyos,&nbsp;and&nbsp;Sotyktu,&nbsp;partially offset by&nbsp;Opdivo&nbsp;and&nbsp;Abecma.
Revenues for the Legacy Portfolio in the first quarter were&nbsp;$7.1 billion, primarily driven by a 9% increase in&nbsp;Eliquis&nbsp;worldwide revenues on a reported basis and, when adjusted for foreign exchange impacts, partially offset by a decline in&nbsp;Revlimid&nbsp;worldwide revenues of 5%, or 4%.
The company reported an adjusted EPS loss of $(4.40), compared to an income of&nbsp;$2.05 a year&nbsp;ago, beating the consensus loss of $(4.44).
Also&nbsp;Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/04/38143938/bristol-myers-14b-bet-on-schizophrenia-drug-cuts-symptoms-without-common-side-effect-of-weight-ga" rel="noreferrer noopener">Bristol Myers&#8217; $14B Bet On Schizophrenia &#8211; Drug Cuts Symptoms Without Common Side Effect Of Weight Gain Associated With Other&nbsp;Antipsychotics</a>
Bristol Myers Squibb also said it is executing a productivity initiative to drive approximately&nbsp;$1.5 billion&nbsp;in cost savings by the end of 2025.&nbsp;
The WSJ noted that Bristol Myers Squibb will shed 2,200 employees as a part of the cost-cutting program.
William Blair&nbsp;says Reblozyl stood out among new product launches in the quarter, generating $354 million in sales, slightly exceeding their estimated $349 million.&nbsp;
However, investors are primarily concerned about the overall performance of the new product portfolio, which fell short of expectations.
The analyst suggests that revealing the favorable Phase II outcomes of Opdualag in non-small-cell lung cancer could signify a significant shift in the storyline. The press release highlights the commencement of the Phase 3 trial in a crucial&nbsp;sector of the disease&nbsp;in 2024.
Guidance:&nbsp;Bristol Myers Squibb revises 2024 adjusted EPS guidance from $7.10-$7.40 to $0.40-$0.70 versus consensus of $0.66, reflecting the impact of recent transactions.
Read Next:&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/04/38114915/fda-approves-bristol-myers2seventy-bios-abecma-for-earlier-use-in-pretreated-blood-cancer-patient" rel="noreferrer noopener">FDA Approves Bristol-Myers/2seventy Bio&#8217;s Abecma For Earlier Use In Pretreated Blood Cancer Patients With Updated Boxed Warning On Secondary Cancer</a>.
Price Action: BMY shares are down 8.12% at $44.90 at the last check Thursday.
Photo via Shutterstock

Biotech

Earnings

Large Cap

Guidance

Health Care

Movers

Trading Ideas

General

Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions

JP Morgan analyst Harlan Sur maintains Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) with a Overweight and raises the price target from $900 to $950.

LRCX

JP Morgan Maintains Overweight on Lam Research, Raises Price Target to $950

Northrop Grumman Corp&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) reported&nbsp;first-quarter fiscal 2024&nbsp;sales growth of 9% year-over-year to $10.133 billion,&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38425743/northrop-grumman-releases-first-quarter-2024-financial-results" rel="noreferrer noopener">beating the consensus of $9.771 billion.</a>
First-quarter EPS was $6.32 compared to $5.50 a year ago,&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">beating the consensus of $5.74.</a>
&#8220;Robust global defense spending and our strong backlog, along with expanding margins, continue to support our multi-year outlook for free cash flow growth,&#8221; commented Kathy Warden, chair, chief executive officer, and president.
Sales by segments: Aeronautics Systems $2.97 billion (+18% Y/Y), Defense Systems $1.41 billion (+3% Y/Y), Mission Systems $2.66 billion (+4% Y/Y), and Space Systems $3.65 billion (+9% Y/Y).
Segment operating income rose 10% Y/Y to $1.1 billion, and margin expanded by&nbsp;10&nbsp;bps to 10.9%. Total operating margin expanded by 40 bps to 10.6%.
NOC&#8217;s first-quarter net awards totaled $6.5 billion, and its backlog totaled $78.9 billion. Significant&nbsp;first quarter&nbsp;new awards include $3.1 billion for restricted programs.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/government/24/04/38321271/northrop-grumman-and-elon-musks-spacex-forge-alliance-for-us-spy-satellite-initiative" rel="noreferrer noopener">Northrop Grumman And Elon Musk&#8217;s SpaceX Forge Alliance for US Spy Satellite Initiative</a>
The company&#8217;s operating cash used in operating activities for the quarter totaled $(706) million (-1% Y/Y), and free cash outflow stood at $(976) million (+3% Y/Y).
Northrop Grumman returned $1.5 billion to investors via dividends and share repurchases and expects greater than $2 billion in 2024 share repurchases.&nbsp;&nbsp;
Fiscal 2024 Outlook, reaffirmed:&nbsp;Northrop Grumman sees sales of $40.8 billion – $41.2 billion versus the consensus of $41.11 billion; The company sees MTM-adjusted EPS of $24.45-$24.85 (consensus $24.65).
It sees Segment operating income of $4.475 billion-$4.55 billion and an adjusted free cash flow of $2.25 billion-$2.65 billion for 2024.
Price Action: NOC shares traded higher by 1.56% at $481.98 at the last check Thursday.
Photo via Wikimedia Commons

Equities

Northrop Grumman Reaffirms 2024 Guidance Post Double-Digit Earnings Growth In Q1: Details

RBC Capital analyst Jon Arfstrom maintains SLM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLM#NASDAQ">SLM</a>) with a Outperform and raises the price target from $24 to $25.

RBC Capital Maintains Outperform on SLM, Raises Price Target to $25

Shares of Strategic Education Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRA#NASDAQ">STRA</a>) are trading higher after the company reported first-quarter 2024 sales growth of 13.1% year-on-year to $290.3 million, <a href="https://www.benzinga.com/pressreleases/24/04/b38425092/strategic-education-inc-reports-first-quarter-2024-results">beating the analyst's consensus estimate of $273.635 million.</a>
Total costs and expenses fell 3.6% year-over-year to $248.9 million.
The operating margin was 14.2%, and operating income for the quarter was $41.4 million compared to an operating loss of $1.3 million last year. Adjusted operating income margin expanded 920 basis points to 13.9%.
Adjusted EBITDA was $54.3 million versus $27.2 million last year.
Adjusted EPS of $1.11 <a href="https://www.benzinga.com/calendars/earnings">beat the consensus</a> of $0.59.
The company held $222.1 million in cash and equivalents as of March 31, 2024. Cash provided by operating activities for the quarter totaled $35.2 million.
Strategic Education declared a regular quarterly cash dividend of $0.60 per share, payable on June 3, 2024 to shareholders of record as of May 24, 2024.
&#8220;The U.S. Higher Education segment delivered another quarter of strong growth driven by employer affiliated enrollment; the Education Technology Services segment continued to see strength, including from Sophia subscriptions; and the Australia/New Zealand segment returned to total enrollment growth,&#8221; said CEO Karl McDonnell.
Price Action: STRA shares are trading higher by 11.9% at $112.62 at the last check Thursday.
Image: Shutterstock

STRA

Why Strategic Education Shares Are Soaring Today?

JP Morgan analyst Seth Seifman maintains General Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) with a Overweight and raises the price target from $280 to $298.

JP Morgan Maintains Overweight on General Dynamics, Raises Price Target to $298

RBC Capital analyst Mike Dahl maintains Owens-Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) with a Outperform and raises the price target from $175 to $192.

RBC Capital Maintains Outperform on Owens-Corning, Raises Price Target to $192

JP Morgan analyst Kenneth Worthington maintains CME Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) with a Neutral and raises the price target from $198 to $206.

JP Morgan Maintains Neutral on CME Gr, Raises Price Target to $206

RBC Capital analyst Mike Dahl maintains Masco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAS#NYSE">MAS</a>) with a Outperform and raises the price target from $79 to $80.

RBC Capital Maintains Outperform on Masco, Raises Price Target to $80

Amazon.Com&nbsp;Inc. &#8216;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)&nbsp;Amazon Web Services (AWS)&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/24/04/g38426071/gov-holcomb-announces-amazon-web-services-plans-to-invest-11b-to-create-a-new-data-center-campus-i" rel="noreferrer noopener">plans to invest</a>&nbsp;$11 billion to establish a data center campus in north central Indiana, creating at least 1,000 new jobs, as&nbsp;announced Thursday by&nbsp;Governor Eric J. Holcomb, chairman of the Indiana Economic Development Corporation.&nbsp;
Amazon.Com&#8217;s cloud unit&#8217;s investment is&nbsp;Indiana&#8217;s&nbsp;most significant capital investment announcement.
The upcoming data centers will house essential cloud computing infrastructure, including computer servers, data storage drives, networking equipment, and support generative artificial intelligence (AI) technologies.
Also Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38313218/amazon-aims-to-outdo-walmarts-retail-game-boosts-cashierless-tech-in-stores" rel="noreferrer noopener">Amazon Aims to Outdo Walmart&#8217;s Retail Game, Boosts Cashierless Tech in Stores</a>
The Indiana Economic Development Corporation (IEDC) has committed to supporting AWS with&nbsp;data center sales tax exemptions&nbsp;for eligible capital investments over a 50-year term.&nbsp;
Amazon.com is also&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/04/38402886/amazon-to-open-more-cloud-centers-in-southeast-asia-for-better-data-protection" rel="noreferrer noopener">setting up cloud regions</a>&nbsp;in Southeast Asia due to customer demands for secure local data storage.&nbsp;
AWS led the global cloud service market in the fourth quarter, securing 31% of total cloud spending.&nbsp;
Analysts have noted Amazon&#8217;s dominant position in generative AI, foreseeing significant benefits from its AI chip development and diverse&nbsp;large&nbsp;language model offerings.&nbsp;
They also highlighted AWS&#8217;s expected growth, which includes a $545 million quarter-over-quarter increase and a 16% year-over-year rise, marginally exceeding the market&#8217;s 15% expectation.
Ammazon.Com stock gained over 66% in the last 12 months. Investors can gain exposure to the stock via&nbsp;SPDR Select Sector Fund &#8211; Consumer Discretionary&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) and&nbsp;ProShares Online Retail ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONLN#NYSE">ONLN</a>).
Price Action:&nbsp;AMZN shares traded lower by 2.53% at $172.12&nbsp;at&nbsp;the last check Thursday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo by Sundry Photography via Shutterstock

Government

Regulations

Tech

ONLN

Select Sector SPDR-Consumer Discretionary

Amazon's AWS Mega Investment Marks Indiana's Biggest Capital Infusion Ever

NetEase goes ex-dividend tomorrow

Tencent: Don't Panic On The New Gaming Rules

NetEase: I Am Buying The Sell-Off

These Communication Services stocks are trading higher:-Motorsport Games Inc (MSGM) stock is trading at $3.30, an increase of $0.73, or 28.31%, on high volume.  Motorsport Games Inc Cl A gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Buy.  -Abits Group Inc (ABTS)

Communication Services Stocks Moving Up and Down Wednesday: MSGM, ABTS, ATUS, NCTY, SLE, NETTF, NTES, TEO

These Communication Services stocks are trading higher:-Cimpress PLC (CMPR) stock is trading at $91.00, an increase of $15.78, or 20.69%, on high volume.  Cimpress N.V. Ord gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $95.0